Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Journal of Hepatocellular Carcinoma
Volume Volume 8, Issue -, Pages 1367-1373
Publisher
Informa UK Limited
Online
2021-11-13
DOI
10.2147/jhc.s337936
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Do pentraxin 3 and neural pentraxin 2 have different facet function in hepatocellular carcinoma?
- (2021) Manuela Cabiati et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients
- (2020) Susanne Feder et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Drivers and regulators of humoral innate immune responses to infection and cancer
- (2020) Deepak Kumar et al. MOLECULAR IMMUNOLOGY
- Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma
- (2020) Guangrong Wang et al. Scientific Reports
- Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection
- (2020) Huan Deng et al. Scientific Reports
- Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage
- (2019) Ping Luo et al. PATHOLOGY & ONCOLOGY RESEARCH
- Innate immunity, inflammation and tumour progression: double‐edged swords
- (2019) A. Mantovani et al. JOURNAL OF INTERNAL MEDICINE
- Pentraxin 3 in Cardiovascular Disease
- (2019) Giuseppe Ristagno et al. Frontiers in Immunology
- The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis
- (2019) Rémi Porte et al. Frontiers in Immunology
- The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer
- (2019) Andrea Doni et al. Frontiers in Immunology
- Long pentraxin 3: A novel multifaceted player in cancer
- (2018) Arianna Giacomini et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer
- (2018) Cecilia Garlanda et al. PHYSIOLOGICAL REVIEWS
- Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition
- (2018) Tao Song et al. Journal of Cancer
- Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma
- (2018) Ping An et al. Frontiers in Genetics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV
- (2015) R. F. Carmo et al. JOURNAL OF VIRAL HEPATITIS
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
- (2015) Aparna Schweitzer et al. LANCET
- Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival
- (2015) Qianqian Zhu et al. Oncotarget
- Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function
- (2015) Bongkun Choi et al. Oncotarget
- Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer
- (2014) G. Stallone et al. CANCER RESEARCH
- Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis
- (2014) Na Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma
- (2013) S Kondo et al. BRITISH JOURNAL OF CANCER
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Biomarkers for early diagnosis of hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET ONCOLOGY
- Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma
- (2011) E. P. Diamandis et al. CLINICAL CANCER RESEARCH
- Evolution of the Pentraxin Family: The New Entry PTX4
- (2010) Y. Martinez de la Torre et al. JOURNAL OF IMMUNOLOGY
- An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm
- (2009) Barbara Bottazzi et al. Annual Review of Immunology
- Diagnosis and Treatment of Hepatocellular Carcinoma
- (2008) Hashem B. El-Serag et al. GASTROENTEROLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started